Interesting daysHaving followed this stock for a few years, it amazes me how we got this far and then are stalled.
Waiting for the approval of this funding/trial is difficult at best. Without the funding, the company was going nowhere. As mentioned, someone didn't like the deal. Long-time shareholders are being diluted by 2/3 if and when the deal goes through and presumably, the mutual funds buy up all their warrants.
Do they know more than we? Probably and so that is why they are in the hunt for more.
This trial is going to be very interesting and we'll see, imo, by the end of the year, some results and indications whether or not this is a successful treatment.
They will be testing against a "control" of the most difficult/sickest patients. Indications of success will be available within 28 days and after months?/year, they will release an "interim" report. That will be another milestone, after funding, initiating the trial, which will determine the share price.
This "treatment" is not for all sepsis patients! There are many ways to "get" sepsis.
Sepsis has come to the forefront in recent years and maybe the "cause" of complications from surgery, that arises. Does Toraymyxin work on those patients? Don't know.
Interesting scenario about the price nowadays. I suppose that I would like .40 shares but have enough already. I'm thinking that the mutual funds involved are pretty astute but then, some of them have had shares in this company for years and that hasn't worked out so well.